Experimental investigation shows Gastrodia elata reduces neuroinflammation and improves epilepsy outcomes in rats, suggesting therapeutic potential.
Background: Gastrodia elata (GE) is a traditional Chinese herb, a type of Orchidaceae, which has antiepileptic and anti-inflammatory effects. Objectives: To investigate the impact of GE on behavioral changes and inflammation after induction of seizures in rats using pentylenetetrazole. Materials and Methods: Adult male albino rats aged between 10 and 12 weeks, weighing 250–300 g were enrolled in this study. A total of 25 rats were divided into five groups: group 1: control group; group 2: pentylenetetrazole (40 mg/kg); group 3: pentylenetetrazole (40 mg/kg) and GE (883.56 mg/kg); group 4: pentylenetetrazole (40 mg/kg) and lacosamide (LCM, 50 mg/kg); and group 5: LCM (50 mg/kg). The rats were sacrificed by decapitation after 15 days of treatment, and brain tissue homogenate for the estimation of biochemical parameters, such as tumor necrosis factor-alpha (TNF-α), histology, and behavioral tests (latency, duration, and severity of fits). Results: TNF-α in group 2 was increased compared with group 1, but it was significantly decreased in groups 3, 4, and 5 compared with group 2. Histopathological results demonstrated moderate inflammation in group 2 compared with group 1, groups 3, 4, and 5 presented with mild inflammation compared with group 2. Latency of fits was significantly increased in groups 3, 4, and 5, whereas in group 2, it was significantly decreased; duration and severity of fits were significantly decreased in groups 3, 4, and 5. Conclusion: GE had anti-inflammatory effects and alleviated the severity, decreased the duration, and increased the latency of fits.
No takes yet. Share an insight, caveat, or question.
Alebadi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: